How much did Monash IVF Group achieve in EBIT for the current year?
In the current year, Monash IVF Group has achieved an EBIT of 49.77 M AUD.
Monash IVF Group EBIT 2025
Monash IVF Group EBIT
49.77 M AUD
Ticker
MVF.AX
ISIN
AU000000MVF3
WKN
A116LZ
In 2025, Monash IVF Group's EBIT was 49.77 M AUD, a -987.32% increase from the -5.61 M AUD EBIT recorded in the previous year.
The Monash IVF Group EBIT history
| YEAR | EBIT (undefined AUD) |
|---|---|
| 2027e | 58.37 |
| 2026e | 54.22 |
| 2025e | 49.77 |
| 2024 | -5.61 |
| 2023 | 33.12 |
| 2022 | 28.37 |
| 2021 | 38.65 |
| 2020 | 21.83 |
| 2019 | 32.74 |
| 2018 | 33.16 |
| 2017 | 44.61 |
| 2016 | 45.37 |
| 2015 | 37.9 |
| 2014 | 35.9 |
| 2013 | 30.5 |
| 2012 | 23.8 |
| 2011 | 19.8 |
| 2010 | 2.1 |
Monash IVF Group Revenue, EBIT, Net Income AU000000MVF3 · A116LZ
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Monash IVF Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Monash IVF Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Monash IVF Group’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Monash IVF Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Monash IVF Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Monash IVF Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Monash IVF Group’s growth potential.
Monash IVF Group Revenue, EBIT and net profit per share
| Date | Monash IVF Group Revenue | Monash IVF Group EBIT | Monash IVF Group Net Income |
|---|---|---|---|
| 2027e | 312.06 M undefined | 58.37 M undefined | 36.64 M undefined |
| 2026e | 296.81 M undefined | 54.22 M undefined | 33.84 M undefined |
| 2025e | 280.23 M undefined | 49.77 M undefined | 31.65 M undefined |
| 2024 | 254.96 M undefined | -5.61 M undefined | -6.53 M undefined |
| 2023 | 213.59 M undefined | 33.12 M undefined | 21.84 M undefined |
| 2022 | 192.29 M undefined | 28.37 M undefined | 18.41 M undefined |
| 2021 | 183.61 M undefined | 38.65 M undefined | 25.33 M undefined |
| 2020 | 145.42 M undefined | 21.83 M undefined | 11.73 M undefined |
| 2019 | 151.98 M undefined | 32.74 M undefined | 19.85 M undefined |
| 2018 | 150.64 M undefined | 33.16 M undefined | 21.35 M undefined |
| 2017 | 155.18 M undefined | 44.61 M undefined | 29.62 M undefined |
| 2016 | 156.56 M undefined | 45.37 M undefined | 28.78 M undefined |
| 2015 | 124.96 M undefined | 37.9 M undefined | 21.37 M undefined |
| 2014 | 114 M undefined | 35.9 M undefined | 2.6 M undefined |
| 2013 | 96.6 M undefined | 30.5 M undefined | -14.9 M undefined |
| 2012 | 93.2 M undefined | 23.8 M undefined | -15.3 M undefined |
| 2011 | 83.5 M undefined | 19.8 M undefined | -13.4 M undefined |
| 2010 | 75.8 M undefined | 2.1 M undefined | -23.1 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2010 | 75.8 M AUD | 2.1 M AUD | -23.1 M AUD |
| 2011 | 83.5 M AUD | 19.8 M AUD | -13.4 M AUD |
| 2012 | 93.2 M AUD | 23.8 M AUD | -15.3 M AUD |
| 2013 | 96.6 M AUD | 30.5 M AUD | -14.9 M AUD |
| 2014 | 114 M AUD | 35.9 M AUD | 2.6 M AUD |
| 2015 | 124.96 M AUD | 37.9 M AUD | 21.37 M AUD |
| 2016 | 156.56 M AUD | 45.37 M AUD | 28.78 M AUD |
| 2017 | 155.18 M AUD | 44.61 M AUD | 29.62 M AUD |
| 2018 | 150.64 M AUD | 33.16 M AUD | 21.35 M AUD |
| 2019 | 151.98 M AUD | 32.74 M AUD | 19.85 M AUD |
| 2020 | 145.42 M AUD | 21.83 M AUD | 11.73 M AUD |
| 2021 | 183.61 M AUD | 38.65 M AUD | 25.33 M AUD |
| 2022 | 192.29 M AUD | 28.37 M AUD | 18.41 M AUD |
| 2023 | 213.59 M AUD | 33.12 M AUD | 21.84 M AUD |
| 2024 | 254.96 M AUD | -5.61 M AUD | -6.53 M AUD |
| 2025e | 280.23 M AUD | 49.77 M AUD | 31.65 M AUD |
| 2026e | 296.81 M AUD | 54.22 M AUD | 33.84 M AUD |
| 2027e | 312.06 M AUD | 58.37 M AUD | 36.64 M AUD |
Monash IVF Group stock margins AU000000MVF3 · A116LZ
The Monash IVF Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Monash IVF Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Monash IVF Group.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Monash IVF Group's sales revenue. A higher gross margin percentage indicates that the Monash IVF Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Monash IVF Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Monash IVF Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Monash IVF Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Monash IVF Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Monash IVF Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Monash IVF Group Margin History
| Monash IVF Group Gross margin | Monash IVF Group Profit margin | Monash IVF Group EBIT margin | Monash IVF Group Profit margin |
|---|---|---|---|
| 2027e | 89.57 % | 18.7 % | 11.74 % |
| 2026e | 89.57 % | 18.27 % | 11.4 % |
| 2025e | 89.57 % | 17.76 % | 11.29 % |
| 2024 | 89.57 % | -2.2 % | -2.56 % |
| 2023 | 89.51 % | 15.51 % | 10.22 % |
| 2022 | 89.71 % | 14.75 % | 9.57 % |
| 2021 | 89.17 % | 21.05 % | 13.8 % |
| 2020 | 88.72 % | 15.01 % | 8.06 % |
| 2019 | 89.77 % | 21.54 % | 13.06 % |
| 2018 | 90.36 % | 22.01 % | 14.18 % |
| 2017 | 91.59 % | 28.75 % | 19.09 % |
| 2016 | 90.8 % | 28.98 % | 18.38 % |
| 2015 | 89.59 % | 30.33 % | 17.1 % |
| 2014 | 90 % | 31.49 % | 2.28 % |
| 2013 | 92.24 % | 31.57 % | -15.42 % |
| 2012 | 93.24 % | 25.54 % | -16.42 % |
| 2011 | 93.41 % | 23.71 % | -16.05 % |
| 2010 | 91.69 % | 2.77 % | -30.47 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2010 | 91.69 % | 2.77 % | -30.47 % |
| 2011 | 93.41 % | 23.71 % | -16.05 % |
| 2012 | 93.24 % | 25.54 % | -16.42 % |
| 2013 | 92.24 % | 31.57 % | -15.42 % |
| 2014 | 90 % | 31.49 % | 2.28 % |
| 2015 | 89.59 % | 30.33 % | 17.1 % |
| 2016 | 90.8 % | 28.98 % | 18.38 % |
| 2017 | 91.59 % | 28.75 % | 19.09 % |
| 2018 | 90.36 % | 22.01 % | 14.18 % |
| 2019 | 89.77 % | 21.54 % | 13.06 % |
| 2020 | 88.72 % | 15.01 % | 8.06 % |
| 2021 | 89.17 % | 21.05 % | 13.8 % |
| 2022 | 89.71 % | 14.75 % | 9.57 % |
| 2023 | 89.51 % | 15.51 % | 10.22 % |
| 2024 | 89.57 % | -2.2 % | -2.56 % |
| 2025e | 89.57 % | 17.76 % | 11.29 % |
| 2026e | 89.57 % | 18.27 % | 11.4 % |
| 2027e | 89.57 % | 18.7 % | 11.74 % |
Monash IVF Group Aktienanalyse
What does Monash IVF Group do?
The Monash IVF Group Ltd is a company in Australia specializing in reproductive medicine. It was founded in 1970 by Professor Gab Kovacs, who is considered one of the pioneers in the field of in-vitro fertilization (IVF). The company's history began in a small laboratory in Melbourne, where the first successful IVF procedures were performed. Over time, Monash IVF grew and expanded its focus to include other reproductive treatments such as donor egg programs, sperm donation, and cryopreservation. Monash IVF Group Ltd has since become a leading provider in Australia, with 19 clinics throughout the country. The company is not only active in Australia but also operates clinics in Malaysia and Vietnam. The business model of Monash IVF Group Ltd is centered around helping couples and individuals fulfill their desire to have children. The company offers a wide range of treatments tailored to the individual needs and circumstances of each patient. Among the services offered are not only IVF, donor egg programs, and sperm donation but also other technologies such as intracytoplasmic sperm injection (ICSI) and preimplantation genetic diagnosis (PGD). Monash IVF Group Ltd sees itself as an all-rounder and therefore also offers psychological support and guidance during and after treatments. One of the company's specialties is its comprehensive research work. The Monash IVF Group has a specialized research department actively involved in researching new reproductive technologies. The company collaborates closely with universities and leading scientific institutes to gain the latest insights in this field and achieve the best possible outcomes for its patients. Monash IVF Group Ltd is divided into various divisions, each with different focuses and offerings. The main division is the Monash IVF Clinic, specializing in reproductive health and fertility. Here, all common IVF and fertility treatments are offered. Another division is Monash IVF Fertility Diagnostics, specializing in diagnostics and screening of fertility and reproductive problems. State-of-the-art diagnostic procedures for evaluating male and female fertility are used here. Monash IVF Genomics is another division offering genetic counseling, screening, and diagnostics. Here, couples can determine their genetic risk factors for fertility problems and receive support in making the best possible decisions regarding family planning. In addition to these divisions, Monash IVF Group Ltd also offers specialized services. For example, there is the Monash IVF Donor Program, specializing in the facilitation of anonymous and open donor programs. The Monash IVF DNA Matching can also assist in the search for genetic relatives by utilizing advanced DNA profiling. As a leading company in the field of fertility, Monash IVF Group Ltd offers a wide range of products and services to help couples and individuals fulfill their desire to have children. With a long history of innovation and research, as well as a variety of divisions and offerings, the company is an important provider of reproductive medicine in Australia and beyond. Monash IVF Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Monash IVF Group's EBIT
Monash IVF Group's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Monash IVF Group's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Monash IVF Group's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Monash IVF Group’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Monash IVF Group stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Monash IVF Group.
How has the EBIT of Monash IVF Group developed in recent years?
The EBIT of Monash IVF Group has increased by -987.324% decreased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Monash IVF Group?
The EBIT of Monash IVF Group is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Monash IVF Group pay?
Over the past 12 months, Monash IVF Group paid a dividend of 0.07 AUD . This corresponds to a dividend yield of about 5.69 %. For the coming 12 months, Monash IVF Group is expected to pay a dividend of 0.07 AUD.
What is the dividend yield of Monash IVF Group?
The current dividend yield of Monash IVF Group is 5.69 %.
When does Monash IVF Group pay dividends?
Monash IVF Group pays a quarterly dividend. This is distributed in the months of April, October, April, October.
How secure is the dividend of Monash IVF Group?
Monash IVF Group paid dividends every year for the past 13 years.
What is the dividend of Monash IVF Group?
For the upcoming 12 months, dividends amounting to 0.07 AUD are expected. This corresponds to a dividend yield of 5.67 %.
In which sector is Monash IVF Group located?
Monash IVF Group is assigned to the 'Health' sector.
Wann musste ich die Aktien von Monash IVF Group kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Monash IVF Group from 10/11/2024 amounting to 0.036 AUD, you needed to have the stock in your portfolio before the ex-date on 9/5/2024.
When did Monash IVF Group pay the last dividend?
The last dividend was paid out on 10/11/2024.
What was the dividend of Monash IVF Group in the year 2024?
In the year 2024, Monash IVF Group distributed 0.063 AUD as dividends.
In which currency does Monash IVF Group pay out the dividend?
The dividends of Monash IVF Group are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Monash IVF Group
Our stock analysis for Monash IVF Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Monash IVF Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Monash IVF Group Revenue
- Monash IVF Group Net Income
- Monash IVF Group P/E
- Monash IVF Group P/S
- Monash IVF Group EBIT
- Monash IVF Group Dividend
- Monash IVF Group Stocks
- Monash IVF Group Market capitalization
- Monash IVF Group Debt
- Monash IVF Group Liabilities
- Monash IVF Group Equity
- Monash IVF Group AAQS
- Monash IVF Group Employees
- Monash IVF Group ROE
- Monash IVF Group ROA
- Monash IVF Group ROCE
